企業プロフィール
Deciphera Pharmaceuticals 株価・ニュース・カタリスト
上場廃止
- ティッカー:
- DCPH
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for DCPH.
企業概要
事業概要
Deciphera Pharmaceuticals is an oncology company that has focused on kinase biology and targeted cancer therapies. The company’s commercial and pipeline efforts are rooted in precision oncology.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Deciphera sits in specialty oncology biotechnology.
ビジネスモデルの特徴
Its model depends on commercial execution, clinical development, and the ability to extend its targeted-therapy franchise.
バイオ業界での位置付け
Deciphera is a focused oncology biotech whose valuation is driven by launch performance and pipeline milestones.
今後のカタリスト
- Deciphera's catalysts are QINLOCK, vimseltinib, and any remaining value-realization update that clarifies what is left to drive the story after the transaction backdrop. The next step matters because the stock is really about how much of the old standalone oncology story still has value.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。